Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
The Journal of Reproductive Medicine|July 3, 2002
Twenty-five years' clinical experience with placental site trophoblastic tumorsAndreas J Papadopoulos, Marianne Foskett, Michael J Seckl, et al.Journal of Pediatric Gastroenterology and Nutrition|March 21, 2015
Well-defined and reliable clinical outcome assessments for pediatric Crohn disease: a critical need for drug developmentHaihao Sun, Elektra J Papadopoulos, Jeffrey S Hyams, et al.JAMA Oncology|July 17, 2015
Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review: Perspectives From Industry, the Food and Drug Administration, and the PatientEthan Basch, Cindy Geoghegan, Stephen Joel Coons, et al.European Journal of Immunology|August 15, 2000
Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skinE J Papadopoulos, D J Fitzhugh, C Tkaczyk, et al.Molecular Genetics & Genomic Medicine|February 26, 2024
A new case of sodium-dependent multivitamin transporter defect occurring as a life-threatening condition responsive to early vitamin supplementation and literature reviewF-X Van Vyve, N Mercier, J Papadopoulos, et al.Proceedings of the National Academy of Sciences of the United States of America|May 10, 1994
High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinationsJ Hammer, C Belunis, D Bolin, et al.Journal of Cutaneous Medicine and Surgery|March 22, 2002
Pseudoporphyria: an atypical variant resembling toxic epidermal necrolysisA J Papadopoulos, R A Schwartz, Z Fekete, et al.European Journal of Gynaecological Oncology|May 8, 2007
Tumour M2-PK as a predictor of surgical outcome in ovarian cancer, a prospective cohort studyA S Ahmed, T Dew, F G Lawton, et al.Journal of Cutaneous Medicine and Surgery|October 31, 2001
Pyoderma vegetansA J Papadopoulos, R A Schwartz, R Kapila, et al.European Journal of Gynaecological Oncology|May 8, 2007
M2-PK as a novel marker in ovarian cancer. A prospective cohort studyA S Ahmed, T Dew, F G Lawton, et al.Pageof 9